CN106083860A - A kind of synthesis and purifying process replacing Buddhist nun's intermediate according to Shandong - Google Patents

A kind of synthesis and purifying process replacing Buddhist nun's intermediate according to Shandong Download PDF

Info

Publication number
CN106083860A
CN106083860A CN201610460713.5A CN201610460713A CN106083860A CN 106083860 A CN106083860 A CN 106083860A CN 201610460713 A CN201610460713 A CN 201610460713A CN 106083860 A CN106083860 A CN 106083860A
Authority
CN
China
Prior art keywords
shandong
buddhist nun
triphenylphosphine
synthesis
volume ratio
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201610460713.5A
Other languages
Chinese (zh)
Inventor
陈伟
陈强
公文涛
李建国
王玲
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Amy Kejian (chinese) Biological Medicine Co Ltd
Amicogen China Biopharm Co Ltd
Original Assignee
Amy Kejian (chinese) Biological Medicine Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amy Kejian (chinese) Biological Medicine Co Ltd filed Critical Amy Kejian (chinese) Biological Medicine Co Ltd
Priority to CN201610460713.5A priority Critical patent/CN106083860A/en
Publication of CN106083860A publication Critical patent/CN106083860A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention relates to a kind of synthesis and purifying process replacing Buddhist nun's intermediate according to Shandong, it is exactly 3 (4 Phenoxyphenyl) 1H pyrazoles [3 specifically, 4 d] pyrimidine 4 amine is reacted by Mitsunobu with (s) 1 tertbutyloxycarbonyl 3 hydroxy piperidine, triphenylphosphine, DIAD, de-Boc process obtains intermediate aggregate sample, obtain crude intermediate with solvent crystallization, then crude product mixed solvent method is recrystallized to give the purity process replacing Buddhist nun's intermediate according to Shandong more than 97%.The present invention uses " one kettle way " to obtain according to Shandong for Buddhist nun's intermediate, and course of reaction is simple, and yield is high, additionally provides a kind of efficient process for purification simultaneously.

Description

A kind of synthesis and purifying process replacing Buddhist nun's intermediate according to Shandong
Technical field
The invention belongs to medicine synthesis field, be exactly that 3-(4-Phenoxyphenyl)-1H-pyrazoles [3,4-d] is phonetic specifically Pyridine-4-amine and (s)-1-tertbutyloxycarbonyl-3-hydroxy piperidine, triphenylphosphine, DIAD are reacted by Mitsunobu, de-Boc process Obtain obtaining process according to Shandong for Buddhist nun's intermediate and recrystallization thereof.
Background technology
The treatment lymphoma mantle cell (MCL) developed jointly for Ni Shi pharmacyclics company and Johson & Johnson according to Shandong Medicine, trade name Imbruvica, in October, 2013 through FDA approval listing.Concrete structure is as follows:
Former patent US7514444 of grinding discloses a kind of synthetic method replacing Buddhist nun according to Shandong, and concrete synthetic route is as follows:
Patent CN104557945A discloses another synthetic method replacing Buddhist nun according to Shandong, and concrete synthetic route is as follows:
Above two synthesis replaces the method for Buddhist nun all to experienced by intermediate B according to Shandong, and its Central Plains is ground in patent US7514444 and used Be the method purification intermediate of column chromatography, purge process is time-consuming and is not suitable for large-scale production;Patent CN104557945A is also It is not directed to clear and definite purification of intermediate method, and needs to make Grignard reagent by oneself in course of reaction, also need to price simultaneously The palladium of costliness, the catalyst of nickel class, course of reaction is difficult to control to and cost is high.So, a kind of efficient easy-operating centre of exploitation The purification process of body B has good market prospect.
Summary of the invention
In order to overcome defect of the prior art, this application provides a kind of new according to Shandong for the synthesis of Buddhist nun's intermediate with pure Metallization processes, the application uses " one kettle way " to prepare the crude product of intermediate B, can avoid purification back intermediate, can be with saving of labor Time, cost declining.It addition, use mixed solvent method recrystallization, experimentation is simple, efficient, and reaction condition is relatively mild, is suitable for big Large-scale production.
A kind of synthesis and purifying process replacing Buddhist nun's intermediate according to Shandong, step is as follows:
A kind of synthesis and purifying process replacing Buddhist nun's intermediate according to Shandong, specifically comprises the following steps that
(1) preparation of Buddhist nun's crude intermediate is replaced according to Shandong
By triphenylphosphine dissolved in THF in, be cooler than at 0 DEG C, add (s)-1-tertbutyloxycarbonyl-3-hydroxy piperidine and 3- (4-Phenoxyphenyl)-1H-pyrazoles [3,4-d] pyrimidine-4-amine, is dropwise added drop-wise to reactant liquor system by DIAD after stirring 20 minutes In, react 20 hours at keeping 0 DEG C, concentrate feed liquid the most thick, the 0.5M hydrochloric acid dioxane solution of addition, anti-at 20 DEG C Answer 4 hours, concentrate, add water and ethyl acetate, layering, aqueous phase adds solvent, more alkaline with alkali liquor furnishing, growing the grain 30min, Filter to obtain crude product;
Described triphenylphosphine is 1g/10ml with the mass volume ratio of THF;
Described triphenylphosphine is 1g/30~50ml with the mass volume ratio of hydrochloric acid dioxane solution;
Described triphenylphosphine is 1g/10ml with the mass volume ratio of water or ethyl acetate;
Described triphenylphosphine, (s)-1-tertbutyloxycarbonyl-3-hydroxy piperidine, 3-(4-Phenoxyphenyl)-1H-pyrazoles The ratio of the amount of the material of [3,4-d] pyrimidine-4-amine and DIAD is 1:1:1:1;
(2) preparation of Buddhist nun's intermediate fine work is replaced according to Shandong
Be dissolved in outstanding for step (1) gained crude product in mixed solvent, be heated to reflux to molten clearly, naturally be cooler than at 20 DEG C and stir 12 Hour, it is filtrated to get fine work.
Owing to the impurity in crude product is mainly raw material residual, mixed solvent reaches pure by dissolubility good to raw material The purpose changed.
Solvent described in step (1) is the one in methanol, ethanol, isopropanol, acetone, and triphenylphosphine and solvent Mass volume ratio is 1g/0.5~2.0ml.
Alkali liquor described in step (1) is sodium hydroxide or potassium hydroxide, and concentration is 10%~25%.
Mixed solvent described in step (2) includes two kinds in methanol, ethanol, isopropanol, acetonitrile, ethyl acetate, and Crude intermediate is 1g/5.0~15ml with the mass volume ratio of mixed solvent.
About the innovative point of the present invention, can be illustrated by following aspect:
(1) " one kettle way " prepares the crude product of intermediate B, can avoid purification back intermediate, can drop into saving working hour This.Former patent of grinding is separated the intermediate before intermediate B by the method for column chromatography, and the present invention is directly with " one kettle way " Obtain Crude Intermediate B, not only save a lot of mask work, additionally it is possible to large-scale production.
(2) using mixed solvent method recrystallization, experimentation is simple, efficient, and reaction condition is relatively mild, is suitable for extensive Produce.
Detailed description of the invention:
Embodiment one:
By 10.0g (38.2mmol 1.0eq) triphenylphosphine dissolved in 100ml THF, it is cooler than at 0 DEG C, adds 7.67g (38.2mmol 1.0eq) (s)-1-tertbutyloxycarbonyl-3-hydroxy piperidine and 11.5g (38.2mmol 1.0eq) 3-(4-phenoxy group Phenyl)-1H-pyrazoles [3,4-d] pyrimidine-4-amine, after stirring 20 minutes, 7.67g (38.2mmol 1.0eq) DIAD is dropwise dripped In reactant liquor system, react 20 hours at keeping 0 DEG C.Then concentrate feed liquid the most thick, add 380ml 0.5M hydrochloric acid two Oxygen six ring solution, reacts 4 hours at 20 DEG C, concentrates, and adds 100ml water and 100ml ethyl acetate, layering, adds in aqueous phase 20ml methanol, then it is adjusted to pH=10-11, growing the grain 30min with the sodium hydrate aqueous solution of 10%, filter to obtain crude product 8.85g, yield 60%.
8.0g crude product is hanged (methanol: ethyl acetate=1:3) in molten 80ml mixed solvent, be heated to reflux to molten clearly, natural It is cooler than at 20 DEG C stirring 12 hours, is filtrated to get intermediate fine work 5.65, yield 63.8%.
Embodiment two:
By 10.0g (38.2mmol 1.0eq) triphenylphosphine dissolved in 100ml THF, it is cooler than at 0 DEG C, adds 7.67g (38.2mmol 1.0eq) (s)-1-tertbutyloxycarbonyl-3-hydroxy piperidine and 11.5g (38.2mmol 1.0eq) 3-(4-phenoxy group Phenyl)-1H-pyrazoles [3,4-d] pyrimidine-4-amine, after stirring 20 minutes, 7.67g (38.2mmol 1.0eq) DIAD is dropwise dripped In reactant liquor system, react 20 hours at keeping 0 DEG C.Then concentrate feed liquid the most thick, add 380ml 0.5M hydrochloric acid two Oxygen six ring solution, reacts 4 hours at 20 DEG C, concentrates, and adds 100ml water and 100ml ethyl acetate, layering, adds in aqueous phase 10ml ethanol, then it is adjusted to pH=10-11, growing the grain 30min with the sodium hydrate aqueous solution of 20%, filter to obtain crude product 9.13g, yield 61.9%.
8.0g crude product is hanged (methanol: acetonitrile=1:2) in molten 64ml mixed solvent, be heated to reflux to molten clearly, be naturally cooler than Stir 12 hours at 20 DEG C, be filtrated to get intermediate fine work 6.11, yield 76.3%.
Embodiment three:
By 10.0g (38.2mmol 1.0eq) triphenylphosphine dissolved in 100ml THF, it is cooler than at 0 DEG C, adds 7.67g (38.2mmol 1.0eq) (s)-1-tertbutyloxycarbonyl-3-hydroxy piperidine and 11.5g (38.2mmol 1.0eq) 3-(4-phenoxy group Phenyl)-1H-pyrazoles [3,4-d] pyrimidine-4-amine, after stirring 20 minutes, 7.67g (38.2mmol 1.0eq) DIAD is dropwise dripped In reactant liquor system, react 20 hours at keeping 0 DEG C.Then concentrate feed liquid the most thick, add 380ml 0.5M hydrochloric acid two Oxygen six ring solution, reacts 4 hours at 20 DEG C, concentrates, and adds 100ml water and 100ml ethyl acetate, layering, adds in aqueous phase 15ml acetone, then it is adjusted to pH=10-11, growing the grain 30min with the potassium hydroxide aqueous solution of 15%, filter to obtain crude product 8.66g, yield 58.7%.
8.0g crude product is hanged (methanol: ethanol=1:1) in molten 56ml mixed solvent, be heated to reflux to molten clearly, be naturally cooler than Stir 12 hours at 20 DEG C, be filtrated to get intermediate fine work 5.94, yield 74.3%.
Embodiment four:
By 10.0g (38.2mmol 1.0eq) triphenylphosphine dissolved in 100ml THF, it is cooler than at 0 DEG C, adds 7.67g (38.2mmol 1.0eq) (s)-1-tertbutyloxycarbonyl-3-hydroxy piperidine and 11.5g (38.2mmol 1.0eq) 3-(4-phenoxy group Phenyl)-1H-pyrazoles [3,4-d] pyrimidine-4-amine, after stirring 20 minutes, 7.67g (38.2mmol 1.0eq) DIAD is dropwise dripped In reactant liquor system, react 20 hours at keeping 0 DEG C.Then concentrate feed liquid the most thick, add 380ml 0.5M hydrochloric acid two Oxygen six ring solution, reacts 4 hours at 20 DEG C, concentrates, and adds 100ml water and 100ml ethyl acetate, layering, adds in aqueous phase 20ml isopropanol, then it is adjusted to pH=10-11, growing the grain 30min with the potassium hydroxide aqueous solution of 20%, filter to obtain crude product 8.12g, receive Rate 55.0%.
8.0g crude product is hanged (acetonitrile: ethyl acetate=3:1) in molten 40ml mixed solvent, be heated to reflux to molten clearly, natural It is cooler than at 20 DEG C stirring 12 hours, is filtrated to get intermediate fine work 6.02, yield 75.2%.

Claims (4)

1. synthesis and the purifying process replacing Buddhist nun's intermediate according to Shandong, it is characterised in that specifically comprise the following steps that
(1) preparation of Buddhist nun's crude intermediate is replaced according to Shandong
By triphenylphosphine dissolved in THF in, be cooler than at 0 DEG C, add (s)-1-tertbutyloxycarbonyl-3-hydroxy piperidine and 3-(4- Phenoxyphenyl)-1H-pyrazoles [3,4-d] pyrimidine-4-amine, after stirring 20 minutes, DIAD is dropwise added drop-wise in reactant liquor system, React 20 hours at keeping 0 DEG C, concentrate feed liquid the most thick, the 0.5M hydrochloric acid dioxane solution of addition, at 20 DEG C, react 4 Hour, concentrate, add water and ethyl acetate, layering, aqueous phase adds solvent, more alkaline with alkali liquor furnishing, growing the grain 30min, mistake Filter to obtain crude product;
Described triphenylphosphine is 1g/10ml with the mass volume ratio of THF;
Described triphenylphosphine is 1g/30~50ml with the mass volume ratio of hydrochloric acid dioxane solution;
Described triphenylphosphine is 1g/10ml with the mass volume ratio of water or ethyl acetate;
Described triphenylphosphine, (s)-1-tertbutyloxycarbonyl-3-hydroxy piperidine, 3-(4-Phenoxyphenyl)-1H-pyrazoles [3,4- D] ratio of amount of material of pyrimidine-4-amine and DIAD is 1:1:1:1;
(2) preparation of Buddhist nun's intermediate fine work is replaced according to Shandong
Be dissolved in outstanding for step (1) gained crude product in mixed solvent, be heated to reflux to molten clearly, naturally be cooler than at 20 DEG C that to stir 12 little Time, it is filtrated to get fine work.
2. replace synthesis and the purifying process of Buddhist nun's intermediate as described in claim 1 according to Shandong, it is characterised in that in step (1) Described solvent is the one in methanol, ethanol, isopropanol, acetone, and the mass volume ratio of triphenylphosphine and solvent is 1g/ 0.5~2.0ml.
A kind of synthesis and purifying process replacing Buddhist nun's intermediate according to Shandong, it is characterised in that step (1) alkali liquor described in is sodium hydroxide or potassium hydroxide, and concentration is 10%~25%.
A kind of synthesis and purifying process replacing Buddhist nun's intermediate according to Shandong, it is characterised in that step (2) mixed solvent described in includes two kinds in methanol, ethanol, isopropanol, acetonitrile, ethyl acetate, and crude intermediate with The mass volume ratio of mixed solvent is 1g/5.0~15ml.
CN201610460713.5A 2016-06-23 2016-06-23 A kind of synthesis and purifying process replacing Buddhist nun's intermediate according to Shandong Pending CN106083860A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201610460713.5A CN106083860A (en) 2016-06-23 2016-06-23 A kind of synthesis and purifying process replacing Buddhist nun's intermediate according to Shandong

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201610460713.5A CN106083860A (en) 2016-06-23 2016-06-23 A kind of synthesis and purifying process replacing Buddhist nun's intermediate according to Shandong

Publications (1)

Publication Number Publication Date
CN106083860A true CN106083860A (en) 2016-11-09

Family

ID=57253049

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201610460713.5A Pending CN106083860A (en) 2016-06-23 2016-06-23 A kind of synthesis and purifying process replacing Buddhist nun's intermediate according to Shandong

Country Status (1)

Country Link
CN (1) CN106083860A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106967071A (en) * 2017-03-24 2017-07-21 福建省微生物研究所 It is a kind of according to Shandong replace Buddhist nun's intermediate isolation and purification method
CN109232581A (en) * 2018-11-28 2019-01-18 福建省微生物研究所 The method for replacing Buddhist nun's intermediate according to Shandong is isolated and purified with zinc chloride

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013003629A2 (en) * 2011-06-28 2013-01-03 Pharmacyclics, Inc. Methods and compositions for inhibition of bone resorption
CN103319488A (en) * 2007-03-28 2013-09-25 环状药物公司 Inhibitors of bruton's tyrosine kinase
WO2014176348A1 (en) * 2013-04-23 2014-10-30 H. Lee Moffitt Cancer Center And Research Institute, Inc. Inhibitors of the ire-1/xbp-1 pathway and methods of using thereof
CN105440040A (en) * 2015-12-23 2016-03-30 浙江京新药业股份有限公司 Ibrutinib purification method

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103319488A (en) * 2007-03-28 2013-09-25 环状药物公司 Inhibitors of bruton's tyrosine kinase
WO2013003629A2 (en) * 2011-06-28 2013-01-03 Pharmacyclics, Inc. Methods and compositions for inhibition of bone resorption
WO2014176348A1 (en) * 2013-04-23 2014-10-30 H. Lee Moffitt Cancer Center And Research Institute, Inc. Inhibitors of the ire-1/xbp-1 pathway and methods of using thereof
CN105440040A (en) * 2015-12-23 2016-03-30 浙江京新药业股份有限公司 Ibrutinib purification method

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
NORA LIU 等: "irect and two-step bioorthogonal probes for Bruton’s tyrosine kinase based on ibrutinib: a comparative study", 《ORGANIC & BIOMOLECULAR CHEMISTRY》 *
XIXIANG LI 等: "Discovery of (R)-1-(3-(4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)-2-(dimethylamino)ethanone (CHMFL-FLT3-122) as a Potent and Orally Available FLT3 Kinase Inhibitor for FLT3-ITD Positive Acute Myeloid Leukemia", 《JOURNAL OF MEDICINAL CHEMISTRY》 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106967071A (en) * 2017-03-24 2017-07-21 福建省微生物研究所 It is a kind of according to Shandong replace Buddhist nun's intermediate isolation and purification method
CN109232581A (en) * 2018-11-28 2019-01-18 福建省微生物研究所 The method for replacing Buddhist nun's intermediate according to Shandong is isolated and purified with zinc chloride

Similar Documents

Publication Publication Date Title
CN106366022B (en) It is a kind of to be used to prepare AZD9291 intermediate and its preparation method and application
CN106083860A (en) A kind of synthesis and purifying process replacing Buddhist nun's intermediate according to Shandong
CN102924380A (en) Preparation method of imidocarb
CN108276414B (en) A kind of preparation method of citric acid tropsch imatinib
CN103980188B (en) The synthetic method of a kind of pyrrole Lun Panai and the synthetic method of intermediate and intermediate thereof
CN108558679A (en) A kind of synthetic method of Parylene A presomas
CN109369608B (en) Method for preparing benzo-1, 3-oxathiolane hexadiene-4-imine
CN104250251B (en) Preparation method for ticagrelor
CN105418613B (en) Environment-friendly preparation method of adenine
CN112409275B (en) Preparation method of photocatalytic 3-acylquinoxalinone compound
CN102260255B (en) Simple and convenient synthesis method of 9,10-dimethoxy-1,3,4,6,7,11b-hexahydro-3-isobutyl-2H-benzo[a] quinolizidine-2-ketone
CN101307019A (en) Method for preparing N-amino-3-azabicyclo[3,3,0]octane hydrochloride
CN105348285A (en) Low-cost and high-yield adenine preparation method
CN114276355B (en) Preparation method of ibrutinib
CN102603595A (en) Preparation method of (S)-oxiracetam
CN101613349B (en) Preparation method of S-3-aminoquinuclidine dihydrochloride
CN101279929B (en) Preparation of optically active 3-amino-N-cyclopropyl-2-hydroxyl hexanamide
CN111116593A (en) Continuous and low-cost preparation method of imatinib
CN104628718A (en) Method for synthesizing scopolamine and salts thereof
CN109369408A (en) A method of preparing 2- aminopropanol
CN112898277B (en) Preparation method of afatinib intermediate
CN106432089A (en) Synthetic method of histamine dichloride
CN112403514B (en) Catalytic system for preparing azoxystrobin intermediate and preparation method of azoxystrobin
CN114634509A (en) Full continuous flow preparation method of (-) -tetrahydroberberine alkaloid
CN109535025B (en) Preparation method of Evonib intermediate 3, 3-difluorocyclobutylamine hydrochloride

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20161109